치과용 멤브레인 시장 규모, 점유율과 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문 예측(2025-2033년)

Dental Membrane Market Summary

The global dental membrane market size was valued at USD 682.46 million in 2025 and is projected to reach USD 1,186.38 million by 2033, growing at a CAGR of 7.27% from 2026 to 2033. The rising global prevalence of periodontal disease and tooth loss is a key driver of demand in the dental membrane market.

According to the World Health Organization (March 2025), more than 1 billion people worldwide suffer from severe periodontal disease, a leading cause of alveolar bone loss that often requires guided tissue regeneration (GTR) and guided bone regeneration (GBR) procedures using dental membranes. Additionally, a significant proportion of older adults experience partial or complete tooth loss, thereby increasing the need for dental implants and bone regeneration therapies. As tooth loss is frequently accompanied by jawbone resorption, the use of bone grafts and barrier membranes is critical to support successful implant placement and long-term clinical outcomes, thereby sustaining market growth.

The global rise in periodontal disease and tooth loss is directly increasing the clinical use of dental membranes in guided tissue regeneration (GTR) and guided bone regeneration (GBR) procedures. According to World Health Organization data published in March 2025, over 1 billion people worldwide suffer from severe periodontal disease, a condition that routinely requires barrier membranes to prevent epithelial migration and enable controlled tissue regeneration.

Tooth loss further accelerates membrane utilization. Nearly 7% of adults aged 20 years and above and approximately 23% of individuals over 60 years experience complete tooth loss, creating a large patient pool requiring regenerative interventions where dental membranes are a standard of care. A February 2025 report by Humble Memorial Dental estimates that 3.5 billion people globally are affected by oral diseases, with nearly 50% of adults aged 30 and above experiencing gum disease, underscoring sustained procedural demand.

Global Dental Membrane Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global dental membrane market report based on product, application, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Resorbable Membranes
  • Bovine -derived collagen based
  • Porcine derived collagen based
  • Others
• Non- Resorbable Membrane
  • Expanded PTFE (ePTFE)
  • Dense PTFE (dPTFE)
  • Titanium-Reinforced PTFE
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Ridge Augmentation
• Sinus Lift
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Socket Preservation
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dental Membrane Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising burden of dental disorders
    • 3.2.1.2. Aging and population growth accelerating severe periodontitis burden
    • 3.2.1.3. Expanding implant and peri-implant defect management using membranes
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Procedure cost and uneven access to advanced dental care
    • 3.2.2.2. Technique sensitivity and post-surgical complications impacting adoption
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Next-generation materials (synthetic polymers, improved biocompatibility and handling)
    • 3.2.3.2. Performance-optimized collagen membranes
    • 3.2.3.3. Policy momentum toward broader oral-health coverage and prevention
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Consistency of clinical outcomes across defect types and real-world settings
    • 3.2.4.2. Balancing resorbable vs non-resorbable choices amid exposure risk and retreatment
• 3.3. Dental Membrane Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Dental Membrane Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Dental Membrane Market Product Movement Analysis
• 4.3. Global Dental Membrane Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
  • 4.3.1. Resorbable membranes
    • 4.3.1.1. Resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.3.1.2. Bovine -derived collagen based
      • 4.3.1.2.1. Bovine -derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.3.1.3. Porcine derived collagen based
      • 4.3.1.3.1. Porcine derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.3.1.4. Others
      • 4.3.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.3.2. Non resorbable membranes
    • 4.3.2.1. Non resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.3.2.2. Expanded PTFE (ePTFE)
      • 4.3.2.2.1. Expanded PTFE (ePTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.3.2.3. Dense PTFE (dPTFE)
      • 4.3.2.3.1. Dense PTFE (dPTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.3.2.4. Titanium-Reinforced PTFE
      • 4.3.2.4.1. Titanium-reinforced PTFE market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Dental Membrane Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Dental Membrane Market Application Movement Analysis
• 5.3. Global Dental Membrane Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Ridge Augmentation
  • 5.4.1. Ridge augmentation market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Sinus Lift
  • 5.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
• 5.6. Periodontal Defect Regeneration
  • 5.6.1. Periodontal defect regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.7. Implant Bone Regeneration
  • 5.7.1. Implant bone regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.8. Socket Preservation
  • 5.8.1. Socket preservation market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Dental Membrane Market: Regional Estimates & Trend Analysis By Product and By Application

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 6.3. North America
  • 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Competitive scenario
    • 6.3.2.3. Regulatory framework
    • 6.3.2.4. Reimbursement scenario
    • 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Competitive scenario
    • 6.3.3.3. Regulatory framework
    • 6.3.3.4. Reimbursement scenario
    • 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Competitive scenario
    • 6.3.4.3. Regulatory framework
    • 6.3.4.4. Reimbursement scenario
    • 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Competitive scenario
    • 6.4.1.3. Regulatory framework
    • 6.4.1.4. Reimbursement scenario
    • 6.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Competitive scenario
    • 6.4.2.3. Regulatory framework
    • 6.4.2.4. Reimbursement scenario
    • 6.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Competitive scenario
    • 6.4.3.3. Regulatory framework
    • 6.4.3.4. Reimbursement scenario
    • 6.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Competitive scenario
    • 6.4.4.3. Regulatory framework
    • 6.4.4.4. Reimbursement scenario
    • 6.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Competitive scenario
    • 6.4.5.3. Regulatory framework
    • 6.4.5.4. Reimbursement scenario
    • 6.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 6.4.6. Denmark
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Competitive scenario
    • 6.4.6.3. Regulatory framework
    • 6.4.6.4. Reimbursement scenario
    • 6.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Competitive scenario
    • 6.4.7.3. Regulatory framework
    • 6.4.7.4. Reimbursement scenario
    • 6.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Competitive scenario
    • 6.4.8.3. Regulatory framework
    • 6.4.8.4. Reimbursement scenario
    • 6.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement scenario
    • 6.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 6.5.2. India
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 6.5.3. China
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 6.5.4. South Korea
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Competitive scenario
    • 6.5.5.3. Regulatory framework
    • 6.5.5.4. Reimbursement scenario
    • 6.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Competitive scenario
    • 6.5.6.3. Regulatory framework
    • 6.5.6.4. Reimbursement scenario
    • 6.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement scenario
    • 6.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement scenario
    • 6.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Global Key company market share analysis, 2025
  • 7.3.4. Institut Straumann AG
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Dentsply Sirona
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Nobel Biocare Services AG (Envista)
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Geistlich Holding
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. ZimVie Inc.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Osteogenics Biomedical (Envista)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Regenity
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. BioHorizons
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. REGEDENT AG
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Bioteck S.p.A.
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. EUCARE PHARMACEUTICALS (P) LTD
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. Curasan, Inc.
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives
  • 7.3.16. TBR Dental
    • 7.3.16.1. Company overview
    • 7.3.16.2. Financial performance
    • 7.3.16.3. Product benchmarking
    • 7.3.16.4. Strategic initiatives
  • 7.3.17. DentiumUSA
    • 7.3.17.1. Company overview
    • 7.3.17.2. Financial performance
    • 7.3.17.3. Product benchmarking
    • 7.3.17.4. Strategic initiatives
  • 7.3.18. Tecnoss Dental Srl
    • 7.3.18.1. Company overview
    • 7.3.18.2. Financial performance
    • 7.3.18.3. Product benchmarking
    • 7.3.18.4. Strategic initiatives
  • 7.3.19. Unicare Biomedical, Inc.
    • 7.3.19.1. Company overview
    • 7.3.19.2. Financial performance
    • 7.3.19.3. Product benchmarking
    • 7.3.19.4. Strategic initiatives
  • 7.3.20. Neoss
    • 7.3.20.1. Company overview
    • 7.3.20.2. Financial performance
    • 7.3.20.3. Product benchmarking
    • 7.3.20.4. Strategic initiatives
  • 7.3.21. Advanced Medical Solutions Group plc
    • 7.3.21.1. Company overview
    • 7.3.21.2. Financial performance
    • 7.3.21.3. Product benchmarking
    • 7.3.21.4. Strategic initiatives
  • 7.3.22. Maxigen Biotech Inc.
    • 7.3.22.1. Company overview
    • 7.3.22.2. Financial performance
    • 7.3.22.3. Product benchmarking
    • 7.3.22.4. Strategic initiatives
  • 7.3.23. B&B Dental Implant Company
    • 7.3.23.1. Company overview
    • 7.3.23.2. Financial performance
    • 7.3.23.3. Product benchmarking
    • 7.3.23.4. Strategic initiatives
• 7.4. Heat Map Analysis/ Company Market Position Analysis
• 7.5. Estimated Company Market Share Analysis, 2025
• 7.6. List of Other Key Market Players